Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PBLA Panbela Therapeutics Inc

0.063 (12.38%)
Last Updated: 13:36:45
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Panbela Therapeutics Inc PBLA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.063 12.38% 0.572 13:36:45
Open Price Low Price High Price Close Price Prev Close
0.5421 0.5301 0.65 0.509
more quote information »

Recent News

Date Time Source Heading
11/29/202308:15GLOBEPanbela Announces 2nd Independent Safety Review of the..
11/24/202316:30EDGAR2Form DEF 14A - Other definitive proxy statements
11/22/202317:01EDGAR2Form S-1 - General form for registration of securities under..
11/17/202317:10EDGAR2Form D - Notice of Exempt Offering of Securities
11/09/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202316:10EDGAR2Form 8-K - Current report
11/09/202316:10GLOBEPanbela Provides Business Update and Reports Q3 2023..
11/03/202317:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/03/202317:24EDGAR2Form 8-K - Current report
11/03/202307:55GLOBEPanbela Therapeutics Announces Exercise of Warrants and..
11/02/202308:15GLOBEPanbela Announces Publication of Preclinical and Clinical..
10/31/202308:15GLOBEPanbela Announces Validation of European Patent in UK,..
10/25/202308:15GLOBEAcceptance of Polyamine Inhibitor CAR-T Combination Abstract..
10/24/202308:15GLOBEPanbela to Host Third Quarter 2023 Earnings Conference Call..
9/26/202308:15GLOBEPanbela Announces Issuance of New Patent in China for Claims..
9/19/202308:15GLOBEPanbela to Present at the LD Micro Investor Conference
9/14/202316:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/05/202308:15GLOBEPanbela Announces Issuance of New Patent in Chile for Claims..
8/28/202308:15GLOBEPanbela to Present at H.C. Wainwright 25th Annual Global..
8/14/202308:15GLOBEPanbela Announces Issuance of New Patent in Europe for..
8/10/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202316:11EDGAR2Form 8-K - Current report
8/10/202316:10GLOBEPanbela Provides Business Update and Reports Q2 2023..
7/31/202316:15GLOBEPanbela to Host Second Quarter 2023 Earnings Conference Call..
7/24/202308:15GLOBEPanbela Opens Enrollment in UK and Germany for Aspire Trial..
7/19/202308:02EDGAR2Form 8-K - Current report
7/19/202308:00GLOBEPanbela Therapeutics to Receive a Total Up to $9.5 Million..
7/17/202306:00GLOBEPanbela Announces Issuance of New Patent in Australia Patent..
7/10/202316:15EDGAR2Form 8-K - Current report
7/10/202308:15GLOBEPanbela Announces Preliminary Safety Analysis for ASPIRE..
6/28/202308:15GLOBEPanbela Announces PACES S0820 Phase III Trial Passes..
6/26/202308:15GLOBEPanbela Announces Poster Presentation at the Endocrine..
6/21/202316:15GLOBEPanbela Announces Closing of Approximately $8.5 Million..
6/16/202308:15GLOBEPanbela Announces Pricing of Approximately $8.5 Million..
6/13/202308:15GLOBEPanbela Announces Sponsored Research Agreement to Evaluate..
6/01/202308:15GLOBEPanbela Announces Poster Presentation at Immunology of..
5/31/202308:00GLOBEPanbela Announces 1-for-30 Reverse Stock Split Effective..
5/22/202308:15GLOBEPanbela Announces Clinical Trial with Moffitt Cancer Center..
5/04/202316:10GLOBEPanbela Provides Business Update and Reports Q1 2023..
4/24/202308:15GLOBEPanbela to Host First Quarter 2023 Earnings Conference Call..
4/19/202308:15GLOBEPanbela Announces Poster Presentation at American..
4/12/202308:15GLOBEFirst Patient Enrolled in JDRF-Funded Phase II Trial of..
4/11/202308:15GLOBEPanbela Regains Worldwide Rights to Develop and..
4/10/202308:30GLOBEAcceptance of CPP-1X (DFMO) Abstract for Poster Presentation..
4/06/202308:30GLOBEAcceptance of CPP-1X (DFMO) Abstract for Poster Presentation..
4/03/202308:30GLOBEPanbela Announces New Research Agreement with Johns Hopkins..
3/22/202308:30GLOBEPanbela Announces Issuance of New Patent in Japan; Patent is..
3/16/202316:10GLOBEPanbela Provides Business Update and Reports Q4 and FY 2022..
3/08/202308:00GLOBEPanbela to Host Fourth Quarter and Year End 2022 Earnings..
3/07/202308:00GLOBEPanbela Announces First Patient Enrolled in South Korea for..

Your Recent History